Skip to main content

What is hunta virus and it's consequences

HOW IT INFECT THE HUMAN
                
Single standed ,enveloped, negative sense, RNA virus which normally  infect rodents where they don't cause disease (work as reserviour)
SPREAD -  Hunta virus present in the urin and feaces  of rodents , spread of infection when the people are contact with rodents or their dropping or urins or possibly  to inhale virus from droppings.
Very rear possibilities to person to person infection.

ON THE BASIS OF DIFFERENT  TYPES OF STRAINS, VIRUS  AFFECTS  DIFFERENT  ORGANS;

  • In lunga, causing hunta virus pulmonary  syndrome (HPS)
  • In kidney, causing  hemorrahagic fever with renal syndrome (HFRS)
However many symptoms of two infection are overlaps  in initial. 

HUNTA VIRUS PULMONARY  SYNDROME

People with HPS then develope  a cough and shortness of breath, which may become serious , fluid  collects around  the neck and low pressure
Death in up to about 50% of the people .
Those who servive first few day then recovery is about 2-3 week

HEMORRHAGIC FEVER WITH RENAL SYNDROME  
Some people  suffered with hemorrahagic  fever with renal syndrome, infection  is mild don't cause symptom.
Some are suffered with vague mild symptom but recover.
In others, symptoms become severe. Like SHOCK, KIDNEY  FAILURE, ANURIA, HEMATURIA, and BRUISES on their skin.

Death occurs in 6 to 15% .of those who servive, most  recover in 3 to 6 week of age , but recover may take up to 6 month

TREATMENT- There is no specific  treat ment,  cure, and vaccine for hunta virus.


  •  In intensive care.

  • HPS  patients  are incubated and  give oxygen therapy, with suppprtive drugs to stablise pressure.

  • Renal syndrome, patients  are on dialysis therapy and supportive anti viral drug like ribavirin given intravenously .



Comments

Popular posts from this blog

Animal organs for human transplantation: how close are we ?

You know  about xenotransplantation Solid organ transplantation ,by most measure a phenomenal success. One potential  solution to organ availability  crises is the use of animal as organ donar for humans ( xenotransplantation). Organ transplantation has been one of the success  stories of the latter part of 20th century, this field now solidly entrenched in modern medical therapy. Since last decades, thousands of the patients received new kidneys, livers, heart and other organs( lung, pancreas, and intestine ) routinely transplanted, clinical results of these interventions have meant the restoration of meaningful, protective and active lives to recipients of all organs. Vexingly, the transplant community has not been able to meet the demand for donar organ, to reduced the overcome finding  a alternative, more plenityful  supply of replacement organs for human transplantation. THE IDEAL DONOR ANIMAL    A long list emerging when we considered  the preferred characteristics

Modern medical therapy over mesenchymal stem cells in 2018

why modern medical therapy  work on mesenchymal  stem cells (MSCs) Mesenchymal  stem cell are self- renewing, multipotent, progenitor  cell with multilineage potential to differentiate into cell type of mesodermal  origin. SUCH AS - adipocytes, osteocytes and condrocytes,  while MSCs  are most commonly  isolated from bone marrow  by aspiration process, they are also from other tissue including adipose tissue, placenta, amniotic fluid & umbilical card blood. Main resion - due to their accessibility & convenient  protocols, MSCs have been recognised  as promising  for  cellular therapy, regenerative medicines, and tissue  engineering . IN CELLULAR  THERAPY- This processes take 2-3 weeks. This kind of mature  , fully differentiate  cell  phenotype and the noumber  of the cells though this can be influenced in 3 ways. Firstly by varying in initial seed density  in the culture media Secound through changing  the conditions of the medium during  expansion Third &